Andrea Miller
Psychiatric/Mental Health · Okemos, MINPI 1629418041
Payments from drug & device makers
Across 88 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$257
- Sanofi$256
- AstraZeneca$161
- Pfizer$132
- Teva Pharmaceuticals USA, Inc.$116
- Covis Pharma GmbH$60
- plus $665 from 20 others
What the payments were for
- Food & beverage$1,646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 13 | $257 |
| Sanofi | 13 | $256 |
| AstraZeneca | 8 | $161 |
| Pfizer | 9 | $132 |
| Teva Pharmaceuticals USA, Inc. | 7 | $116 |
| Covis Pharma GmbH | 4 | $60 |
| Boehringer Ingelheim | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Neurocrine Biosciences, Inc. | 2 | $58 |
| Alkermes, Inc. | 2 | $53 |
| Grifols USA, LLC | 2 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Novartis | 2 | $44 |
| Genentech USA, Inc. | 3 | $43 |
| Lundbeck LLC | 2 | $39 |
| Optinose US, Inc. | 2 | $31 |
| Kaleo, Inc. | 2 | $30 |
| Biocryst US Sales Co., LLC | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
| Neos Therapeutics, LP | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$107
How this compares
$1,646 in reported general payments places this provider in the 70th percentile of 638 psychiatric/mental health providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 18 | $634 |
| Duloxetine Hcl | 22 | $418 |
| Methylphenidate Hcl | 14 | $242 |
| Mirtazapine | 14 | $240 |
| Prazosin Hcl | 11 | $208 |
| Gabapentin | 14 | $199 |
| Trazodone Hcl | 20 | $178 |
| Quetiapine Fumarate | 11 | $141 |
| Alprazolam | 17 | $93 |
| Zolpidem Tartrate | 14 | $88 |
| Paroxetine Hcl | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Okemos
- Karyn ButlerOkemos$8K
- Miriam AdamOkemos$6K
- Duren GutierrezSouthfield$207K
- Tamlynn EvansTraverse City$78K
- Shiba NixonClarkston$60K
- Amy AmesClinton Township$43K
- Cody ShinavierClarkston$41K
- Oksana LidkeBattle Creek$30K
- Jennifer Wims-MaddenPontiac$28K
- Jessica ShantzWarren$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.